Precision Biosensor Inc.
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
Market Cap & Net Worth: Precision Biosensor Inc. (335810)
Precision Biosensor Inc. (KQ:335810) has a market capitalization of $17.01 Million (₩24.91 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #30635 globally and #2051 in its home market, demonstrating a 1.90% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Precision Biosensor Inc.'s stock price ₩2145.00 by its total outstanding shares 11614526 (11.61 Million).
Precision Biosensor Inc. Market Cap History: 2020 to 2026
Precision Biosensor Inc.'s market capitalization history from 2020 to 2026. Data shows change from $271.68 Million to $17.01 Million (-40.48% CAGR).
Index Memberships
Precision Biosensor Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.00% | #1141 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.00% | #1141 of 1384 |
Weight: Precision Biosensor Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Precision Biosensor Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Precision Biosensor Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Precision Biosensor Inc.'s market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $271.68 Million | $8.68 Billion | -$4.95 Billion | 0.03x | N/A |
| 2021 | $88.05 Million | $15.89 Billion | -$4.15 Billion | 0.01x | N/A |
| 2022 | $47.04 Million | $20.46 Billion | -$6.81 Billion | 0.00x | N/A |
| 2023 | $37.84 Million | $20.39 Billion | -$4.49 Billion | 0.00x | N/A |
| 2024 | $22.41 Million | $19.13 Billion | -$7.31 Billion | 0.00x | N/A |
Competitor Companies of 335810 by Market Capitalization
Companies near Precision Biosensor Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Precision Biosensor Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Precision Biosensor Inc. Historical Marketcap From 2020 to 2026
Between 2020 and today, Precision Biosensor Inc.'s market cap moved from $271.68 Million to $ 17.01 Million, with a yearly change of -40.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩17.01 Million | -19.21% |
| 2025 | ₩21.06 Million | -6.02% |
| 2024 | ₩22.41 Million | -40.78% |
| 2023 | ₩37.84 Million | -19.56% |
| 2022 | ₩47.04 Million | -46.58% |
| 2021 | ₩88.05 Million | -67.59% |
| 2020 | ₩271.68 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Precision Biosensor Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.01 Million USD |
| MoneyControl | $17.01 Million USD |
| MarketWatch | $17.01 Million USD |
| marketcap.company | $17.01 Million USD |
| Reuters | $17.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.